胃腸肝膽科

白明忠

副院長
胃腸肝膽科 :
門診掛號
現職
主要學歷
主要經歷

主治項目或專長

MAJOR SERVICE

消化系內科、一般內科、胃腸肝膽、食道、腹部各種疾病

論文研究

一、期刊論文
1. Wong MW, Chen MJ, Chen HL, Kuo YC, Lin IT, Wu CH, Lee YK, Cheng CH, Bair MJ*; ”Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.” PLoS One. 2017 Aug 2;12(8):e0182529. doi: 10.1371/journal. pone.0182529. eCollection 2017.(SCI)
2.Lin CC, Bair MJ*;“Common hepatitis C treatment side effects in relation to alcohol consumption and racial differences in Southeastern Taiwan.”J Formos Med Assoc. 2016 Dec;115(12):1101-1102. (SCI)
3.Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW,Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, Chen TM, Mo LR, Hsu SJ, Tseng KC, Hsieh TY, Suk FM, Hu CT, Bair MJ, Liang CC, Lei YC, Tseng TC, Chen CL, Kao JH; C-TEAM study group and the Taiwan Liver Diseases Consortium.“Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.”Liver Int. 2016 Dec;36(12):1755-1764. (SCI)
4.Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY, El-Omar EM, Wu MS; “Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.” Lancet. 2016 Nov 12;388(10058):2355-2365. (SCI)
5.Liou JM, Bair MJ, Chen CC, Lee YC, Chen MJ, Chen CC, Tseng CH, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Chang WH, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hung HW, Lin JT, Chang CY, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.“Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial”Am J Gastroenterol. 2016 Mar;111(3):381-7. (SCI)
6.Lin CC, Bair MJ, Chen CJ, Lee KH, Chen MJ, Liu CY, Chang CW, Hu KC, Liou TC, Lin SC, Wang HY, Chu CH, Shih SC, Wang TE;“Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients.” Kaohsiung J Med Sci. 2016 Jan;32(1):10-5. (SCI)
7. Lin CC, Wu CH, Chen HL, Lin IT, Chen MJ, Wang TE, Wang HY, Shih SC, Bair MJ*;“Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan.”J Formos Med Assoc. 2015 Nov;114(11):1069-75. (SCI)
8. Cheng CH, Chen HL, Lin IT, Wu CH, Lee YK, Wong MW, Bair MJ*;“The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response.”Kaohsiung J Med Sci. 2015 Nov;31(11):597-602. (SCI)
9.Liou JM, Chen CC, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Liou TC, Chang WH, Hsu YC, Tseng CH, Chang CC, Bair MJ, Liu TY, Hsieh CF, Tsao FY, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.“Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.”Gut. 2015 Sep 3. pii: gutjnl-2015-310142. (SCI)
10. Liou JM, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Wu JY, Luo JC, Liou TC, Chang WH, Tseng CH, Wu CY, Yang TH, Chang CC, Wang HP, Sheu BS, Lin JT, Bair MJ*, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.“The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.”PLoS One. 2015 May 5;10(5):e0124199. (SCI)
11. Chen CH, Bair MJ, Hsu CW, Chiu TC, Hu CC; “Analysis of steroid hormones in human saliva by matrix-assisted laser desorption/ionization mass spectrometry.” Analytical Methods 2015, 2(7),486-489. (SCI)
12. Jheng GH, Wu IC, Shih HY, Wu MC, Kuo FC, Hu HM, Liu CJ, Hsu WH, Hu CT, Bair MJ, Kuo CH, Wu DC, Hsu PI;“Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection.”Biomed Res Int. 2015;2015:163960. (SCI)
13. Chen LJ, Chen HL, Bair MJ, Wu CH, Lin IT, Lee YK, Chu CH;“Refeeding syndrome in Southeastern Taiwan: our experience with 11 cases.”World J Gastroenterol. 2014 Aug 14;20(30):10525-30. (SCI)
14.Lin CC, Wu CH, Chen HL, Lin IT, Wang SY, Wang TE, Wang HY, Shih SC,Bair MJ*;“Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection.”Ann Hepatol. 2014 Jul-Aug;13(4):350-5. (SCI)
15. Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC; “Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.”World J Gastroenterol. 2014 Jun 28;20(24):7718-29. (SCI)
16. Yang AM, Wen LL, Yang CS, Wang SC, Chen CS, Bair MJ*;“Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients.” Kaohsiung J Med Sci. 2014 Jun;30(6):291-8. (SCI)
17 Chen HL, Chen MJ, Shih SC, Wang HY, Lin IT, Bair MJ*;“Socioeconomic status,personal habits, and prevalence of Helicobacter pylori infection in the inhabitants of Lanyu.”J Formos Med Assoc. 2014 May;113(5):278-83. (SCI)
18. Chen HL, Bair MJ*, Lin IT, Wu CH, Lee YK;“Clinical manifestations and risk factors of amebic liver abscess in Southeast Taiwan compared with other regions of Taiwan.” Am J Trop Med Hyg. 2013 Dec;89(6):1214-8. (SCI)
二、專書章節
1. Ming-Jong Bair, Huan-Lin Chen ,I-Tsung Lin, Chia-Hsien Wu, Yung-Kai Lee; “Percutaneous Endoscopic Gastrostomy in Dementia.” From Diet and Nutrition in Dementia and Cognitive Decline 2014 ,Chapter 107, pp.1143-1148, Editors: Colin Martin Victor Preedy, Imprint: Academic Press, ISBN: 978-0-12-407824-6.

胃腸肝膽科

胃腸肝膽科

白明忠

現職

主要學歷

主要經歷

主治項目或專長

MAJOR SERVICE

論文研究